Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 7
Submit an article Journal homepage
115
Views
5
CrossRef citations to date
0
Altmetric
Cancer

The therapeutic effects of blocking IGF-R1 on mice model of skin cancer

Abdullah AlyoussefDepartment of Internal Medicine (Dermatology), Faculty of Medicine, University of Tabuk, Tabuk, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6311-7538
ORCID Icon
Pages 803-811 | Received 26 Oct 2019, Accepted 19 Dec 2019, Published online: 03 Jan 2020

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Abdullah Alyoussef. (2022) Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis. Toxicology Mechanisms and Methods 32:3, pages 224-232.
Read now

Articles from other publishers (4)

Wenting Liu, Junling Xia, Qingwu Du, Jingya Wang, Ting Mei & Tingting Qin. (2023) Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 149:18, pages 16365-16376.
Crossref
Abdullah Alyoussef. (2022) Antitumor activity of adiponectin in mice model of skin cancer via modulation of sulfatase-2 and MMP9 activity on HSPGs. Biologia.
Crossref
Abdullah Alyoussef. (2020) Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice. Archives of Dermatological Research 313:4, pages 263-273.
Crossref
Soudeh Ghafouri-Fard, Atefe Abak, Mahdi Mohaqiq, Hamed Shoorei & Mohammad Taheri. (2021) The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia. Frontiers in Cell and Developmental Biology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.